GlucoModicum develops the Talisman, a needle-free continuous glucose monitor that utilizes magnetohydrodynamic technology to non-invasively sample interstitial fluid for accurate glucose measurement. This technology provides a pain-free alternative to traditional blood sampling methods, addressing the discomfort and inconvenience associated with glucose monitoring for individuals with diabetes.
Funding
$33.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional continuous glucose monitors (CGMs) rely on invasive needle-based sensors, causing discomfort, inconvenience, and potential skin irritation for individuals with diabetes. Frequent needle insertions can also lead to pain and increase the risk of infection.
Solution
GlucoModicum is developing the Talisman, a needle-free continuous glucose monitor that uses magnetohydrodynamic (MHD) technology to non-invasively sample interstitial fluid for accurate glucose measurement. The Talisman offers a pain-free alternative to traditional blood glucose monitoring, eliminating the need for needles and improving user comfort. This novel approach allows for rapid and gentle glucose monitoring through the skin, providing a more convenient and less intrusive experience for people with diabetes. The device aims to provide continuous glucose readings without the drawbacks associated with current CGM technology.
Target Audience
The primary target audience includes individuals with diabetes who require continuous glucose monitoring and seek a less invasive and more comfortable alternative to traditional needle-based devices.
Features
- Needle-free glucose monitoring using magnetohydrodynamic (MHD) technology
- Non-invasive sampling of interstitial fluid
- Pain-free alternative to traditional CGM devices
- Aims for rapid and gentle glucose measurement through the skin
- Demonstrated strong correlation to blood glucose in clinical studies